NGM·Healthcare·$590M·#365 / 520 in Healthcare
AVR Anteris Technologies Global Cor
32HIGH RISK
CATEGORY BREAKDOWN
GROWTH0
QUALITY26
STABILITY42
VALUATION0
GOVERNANCE85
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
-14.6%
0
> 50% strong
Gross Margin
Revenue retained after direct costs
32.1%
43
> 50% strong
Cash Runway
Months of cash at current burn rate
7 months
16
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
8.8%
93
< 25% strong
Price / Sales
Market cap relative to trailing revenue
308.5x
0
< 3x strong
Rule of 40
Growth rate plus operating margin
-1721
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
16.5%
78
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+0.0%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE AVR WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when AVR's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.